Pfizer/BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose Vaccine Candidate Against COVID-19 and Influenza

...

A combined vaccine for influenza and COVID-19 has the potential to simplify immunization practices against two severe respiratory diseases caused by evolving viruses that require vaccine adaptation.